Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20020062142 A1
Publication typeApplication
Application numberUS 08/942,274
Publication dateMay 23, 2002
Filing dateSep 30, 1997
Priority dateMay 5, 1995
Also published asUS6425912, WO1999016502A1
Publication number08942274, 942274, US 2002/0062142 A1, US 2002/062142 A1, US 20020062142 A1, US 20020062142A1, US 2002062142 A1, US 2002062142A1, US-A1-20020062142, US-A1-2002062142, US2002/0062142A1, US2002/062142A1, US20020062142 A1, US20020062142A1, US2002062142 A1, US2002062142A1
InventorsEdward W. Knowlton
Original AssigneeEdward W. Knowlton
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method and apparatus for tissue remodeling
US 20020062142 A1
Abstract
An apparatus is provided that modifies a skin surface or a soft tissue. The apparatus includes a skin surface conforming member and a hydration delivery device coupled to the conforming member. The hydration delivery device delivers a hydration agent to the skin surface. An energy delivery device is coupled to the conforming member and provides a controlled delivery of energy to the skin surface.
Images(29)
Previous page
Next page
Claims(65)
1. An apparatus for modifying a skin surface or a soft tissue structure underlying a skin surface, comprising:
a skin surface conforming member with a skin interface surface;
a hydration delivery device coupled to the skin interface surface configured to deliver a hydration agent to the skin surface; and
an energy delivery device coupled to the conforming member and providing a controlled delivery of energy to the skin surface.
2. The apparatus of claim 1, further comprising:
a hydration sensor coupled to the conforming member.
3. The apparatus of claim 1, wherein the hydration delivery device includes a hydraulic pressure source.
4. The apparatus of claim 3, wherein the hydration pressure source is a mechanical source.
5. The apparatus of claim 3, wherein the hydration delivery device is an electrical source.
6. The apparatus of claim 3, wherein the hydration delivery device is a thermal source.
7. The apparatus of claim 3, wherein the hydration delivery device is a chemical source.
8. The apparatus of claim 7, wherein the chemical source is ethylene glycol.
9. The apparatus of claim 3, wherein the hydration pressure source is a diffusion gradient.
10. The apparatus of claim 3, wherein the hydration pressure source is a compression source.
11. The apparatus of claim 1, wherein the skin surface conforming member applies a mechanical force to the soft tissue structure.
12. The apparatus of claim 1, further comprising:
a feedback control device coupled the skin surface conforming member.
13. The apparatus of claim 1, further comprising:
a surface pressure sensor coupled to the skin surface conforming member.
14. The apparatus of claim 1, further comprising:
a hydraulic pressure sensor coupled to the skin surface conforming member.
15. The apparatus of claim 1, further comprising:
an impedance sensor coupled to the skin surface conforming member.
16. The apparatus of claim 1, further comprising:
a surface temperature sensor coupled to the skin surface conforming member.
17. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 1000 joules/cm2 during a single treatment session.
18. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 600 joules/cm2 during a single treatment session.
19. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 200 joules/cm2 during a single treatment session.
20. The apparatus of claim 1, wherein the energy delivery device provides a controlled dose rate of energy to the skin surface not exceeding 6 joules/sec/cm2.
21. The apparatus of claim 1, wherein the energy delivery device provides a controlled dose rate energy to the skin surface not exceeding 2 joules/sec/cm2.
22. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to a skin surface to operate in an mpedance range at the skin surface of 70 ohms cm2 measured at a frequency of 88 Hz to 40 Kohms cm2 measured at a frequency of 10 KHz.
23. The apparatus of claim 1, wherein the energy delivery means provides a controlled delivery of energy to operate in a range of thermal conductivity at a skin surface of 0.21 to 0.60 k.
24. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 400 mmHg.
25. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 300 mmHg.
26. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 200 mmHg.
27. The apparatus of claim 1, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 100 mmHg.
28. An apparatus for modifying a skin surface or a soft tissue structure underlying a skin surface, comprising:
a template with a non-conforming skin interface surface that applies an mechanical force through the skin surface;
a hydration delivery device coupled to the non-conforming skin interface surface and configured to deliver a hydration agent to the skin surface; and
an energy delivery device coupled to the non-conforming skin interface surface and provide a controlled delivery of energy to the skin surface.
29. The apparatus of claim 28 further comprising:
a hydration sensor coupled to the non-conforming skin interface surface.
30. The apparatus of claim 28, wherein the hydration delivery device includes a hydraulic pressure source.
31. The apparatus of claim 30, wherein the hydration pressure source is a mechanical source.
32. The apparatus of claim 30, wherein the hydration pressure source is an electrical source.
33. The apparatus of claim 30, wherein the hydration pressure source is a thermal source.
34. The apparatus of claim 30, wherein the hydration pressure source is a chemical source.
35. The apparatus of claim 30, wherein the hydration pressure source is ethylene glycol.
36. The apparatus of claim 30, wherein the hydration pressure source is a diffusion gradient.
37. The apparatus of claim 30, wherein the hydration pressure source is a compression source.
38. The apparatus of claim 28, wherein the template applies a mechanical force to the soft tissue structure.
39. The apparatus of claim 28, further comprising:
a feedback control device coupled to the template.
40. The apparatus of claim 28, further comprising:
a surface pressure sensor coupled to the template.
41. The apparatus of claim 28, further comprising:
a hydraulic pressure sensor coupled to the template.
42. The apparatus of claim 28, further comprising:
an impedance sensor coupled to the template.
43. The apparatus of claim 28, further comprising:
a surface temperature sensor coupled to the template.
44. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 1000 joules/cm2 during a single treatment session.
45. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 600 joules/cm2 during a single treatment session.
46. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to the skin surface not exceeding 200 joules/cm2 during a single treatment session.
47. The apparatus of claim 28, wherein the energy delivery device provides a controlled dose rate of energy to the skin surface not exceeding 6 joules/sec/cm2.
48. The apparatus of claim 28, wherein the energy delivery device provides a controlled dose rate energy to the skin surface not exceeding 2 joules/sec/cm2.
49. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to a skin surface to operate in an impedance range at the skin surface of 70 ohms cm2 measured at a frequency of 88 Hz to 40 Kohms cm2 measured at a frequency of 10 KHz.
50. The apparatus of claim 28, wherein the energy delivery me ans provides a controlled delivery of energy to operate in a range of thermal conductivity at a skin surface of 0.21 to 0.60 k.
51. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 400 mmHg.
52. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 300 mmHg.
53. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 200 mmHg.
54. The apparatus of claim 28, wherein the energy delivery device provides a controlled delivery of energy to operate in a range of compression force applied to the soft tissue structure not exceeding 100 mmHg.
55. A method for tightening a surface of a skin with an underlying collagen containing tissue, comprising:
providing an energy delivery device with an energy delivery surface coupled to a hydration delivery member;
positioning the energy delivery surface on a surface of the skin;
hydrating the surface of the skin;
creating a reverse thermal gradient through the surface of the skin to sufficient heat an underlying collagen containing tissue, wherein a temperature of the surface of the skin is lower than a temperature of the underlying collagen containing tissue; and
tightening at least a portion of the surface of the skin.
56. The method of claim 55, wherein the underlying collagen containing tissue is adjacent to a hair follicle.
57. The method of claim 56, wherein at least a portion of the underlying collagen containing tissue is ablated.
58. The method of claim 56, wherein application of the reverse thermal gradient creates an intracellular suppression of melanin in the hair follicle.
59. The method of claim 55, wherein the underlying collagen containing tissue is adjacent to a sebaceous gland.
60. The method of claim 59, wherein application of the reverse thermal at least partially modifies an oil production function of the sebaceous gland.
61. The method of claim 55, wherein the underlying collagen containing tissue is adjacent to a sweat gland.
62. The method of claim 61, wherein application of the reverse thermal gradient at least partially modifies a production of sweat from the sweat gland.
63. A method for tightening a surface of a skin with an underlying collagen containing tissue, comprising:
providing an energy delivery device with an energy delivery surface coupled to a hydration delivery member;
positioning the energy delivery surface on a surface of the skin;
hydrating the surface of the skin with a hydration agent;
creating a reverse impedance gradient through the surface of the skin to heat an underlying collagen containing tissue, wherein an ECF of a post-hydrated surface of the skin is higher than an ECF of a pre-hydrated state of the surface of the skin; and
tightening at least a portion of the surface of the skin.
64. The method of claim 63, wherein the ECF of the post-hydrated surface of the skin is higher than an ECF of the underlying collagen containing tissue.
65. The method of claim 63, wherein the ECF of the post-hydrated surface of the skin is increased and an ECF of the underlying dermis is lowered.
Description
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a continuation-in-part of U.S. Ser. No. 08/827,237, filed Mar. 28, 1997, which is a continuation-in-part of U.S. patent application Ser. No. 08/583,815, filed Jan. 5, 1996, which is a continuation-in-part of U.S. patent application Ser. No. 08/435,822, filed May 5, 1995. This application also claims the benefit of divisional applications U.S. Ser. No. 08/825,445, filed Mar. 28, 1997 and Ser. No. 08/825,443, filed Mar. 28, 1997, and is also related to Provisional Application Serial No. 60/023,377, filed Aug. 6, 1996.
  • BACKGROUND OF THE INVENTION
  • [0002]
    1. Field of the Invention
  • [0003]
    This invention relates to a method and apparatus for modifying a soft tissue structure underlying a skin surface, and more particularly to a method and apparatus which applies a mechanical force and electromagnetic energy to the soft tissue structure.
  • [0004]
    2. Description of Related Art
  • [0005]
    The correction of a deformity or the esthetic enhancement of a soft tissue structure is determined by the balance of the skin envelope as the container and soft tissue volume as the contents of the container. An appropriate balance between these two components is essential in achieving a successful outcome. Most plastic surgery procedures are based upon the resection or addition of a soft tissue filler with a concomitant modification of the skin envelope. For example, a breast that has three dimensional symmetry with the opposite breast must take into account both the volume of the soft tissue and the surface area of the breast envelope that is required as a container of the tissue. Breast reconstruction after mastectomy typically involves the insertion of a soft tissue replacement for the removed breast tissue. Either an implant or a tissue flap from the patient is used as a soft tissue replacement. Expansion of the breast skin envelope is also required and is achieved with a medical device called a breast expander. While most reconstructive procedures usually involve the addition of a soft tissue filler with the expansion of the skin envelope, many esthetic procedures involve the reduction of the soft tissue contents with or without a reduction in the skin envelope. Reduction in the volume of the soft tissue contents without a concomitant reduction in the skin envelope may lead to a relative excess of the skin envelope. The relative excess will be visualized as loose skin or elastosis. An example of esthetic enhancement is a procedure called breast reduction. This is performed in women who require reduction in the size of their breasts to alleviate shoulder, neck and back symptoms. Breast tissue is resected to reduce volume but also requires a reduction in the breast skin envelope with extensive surgical incisions. Without reduction of the skin envelope of the breast, severe ptosis (droopiness) of the breast will occur.
  • [0006]
    Another example is liposuction which may aggravate elastosis because the soft tissue content is reduced without reduction in the surface area of the skin envelope. The degree of esthetic contour reduction is limited by the preexisting looseness of the skin envelope. Typically, liposuction involves the removal of subcutaneous fat through a suction cannula inserted through the skin surface. Excess suctioning of fat will aggravate any preexisting elastosis. Any other modality that reduces subcutaneous fat through dieting or ablation of fat cells is likely to aggravate a preexisting elastosis if a concomitant reduction of the skin envelope does not occur. This is especially true in the hip and thigh area where a condition called “cellulite” is due to a preexisting looseness of skin. Many patients have a more severe looseness of skin in the hip and thigh area that would be aggravated by any fat removal. Skin tightening procedures that involve large surgical incisions result in severe scarring to the thigh and hip area that are a poor tradeoff to any esthetic contour reduction.
  • [0007]
    There is a need for a method and apparatus to achieve skin tightening without major surgical intervention. There is a further need for a method and apparatus to achieve skin tightening by the controlled remodeling of collagen in the skin and underlying fibrous partitions of the subcutaneous fat. Still a further need exists to tighten a skin envelop with minimal skin or underlying subcutaneous tissue cell necrosis. Yet another need exists to provide a method and apparatus for the controlled remodeling of collagen in tandem with subcutaneous fat ablation in which a net tightening of the skin envelope occurs with an esthetic contour reduction.
  • SUMMARY OF THE INVENTION
  • [0008]
    Accordingly, an object of the invention is to provide a method and apparatus to tighten skin.
  • [0009]
    Another object of the invention is to provide a method and apparatus for creating a reverse thermal gradient through a skin surface.
  • [0010]
    Yet another object of the invention is to provide a method and apparatus for creating a reverse impedance gradient from the skin surface to underlying tissue.
  • [0011]
    Still another object of the invention is to provide a method and apparatus for hydrating the skin.
  • [0012]
    Another object of the invention is to provide a method and apparatus for creating a reverse thermal gradient from the skin to underlying tissue, with the creation of an ablation in the underlying tissue.
  • [0013]
    Yet another object of the invention is to provide a method and apparatus that creates an intracellular suppression of a tissue site underlying the skin surface.
  • [0014]
    A further object of the invention is to provide a method and apparatus that modifies a physiological function of a tissue site underlying the skin.
  • [0015]
    These and other objects of the invention are achieved in an apparatus for modifying a skin surface or a soft tissue structure underlying a skin surface. The apparatus includes a skin surface conforming member and a hydration delivery device coupled to the conforming member. The hydration delivery device delivers a hydration agent to the skin surface. An energy delivery device is coupled to the conforming member and provides a controlled delivery of energy to the skin surface.
  • [0016]
    In one embodiment of the present invention, an apparatus for modifying a skin surface or a soft tissue structure underlying a skin surface includes a template positionable adjacent to the skin surface to apply a mechanical force through the skin surface. A hydration delivery device is coupled to the conforming member and delivers a hydration agent to the skin surface. An energy delivery device is coupled to the conforming template and provides a controlled delivery of energy to the skin surface.
  • [0017]
    In another embodiment, a method produces a tightening of a surface of a skin with an underlying collagen containing tissue. An energy delivery device is provided with an energy delivery surface coupled to a hydration delivery member.
  • [0018]
    The energy delivery surface on a surface of the skin and the surface of the skin is hydrated. A reverse thermal is created through the surface of the skin to heat an underlying collagen containing tissue. The temperature of the surface of the skin is lower than a temperature of the underlying collagen containing tissue and at least a portion of the surface of the skin is tightened.
  • [0019]
    In another embodiment of the invention is a method that tightens a surface of the skin. An energy delivery device is provided with an energy delivery surface coupled to a hydration delivery member. The energy delivery surface is positioned on a surface of the skin and the skin surface is hydrated. A reverse impedance gradient is formed through the skin surface to an underlying collagen containing tissue. An ECF of the surface layers of the skin, stratum corneum, epidermis, and superficial dermis of the skin, is increased and ECF of the underlying collagen containing tissue is decreased in comparison to the pre-hydration state. At least a portion of the skin surface is tightened.
  • BRIEF DESCRIPTION OF THE FIGURES
  • [0020]
    [0020]FIG. 1 is a cross-sectional view of a template of the present invention.
  • [0021]
    [0021]FIG. 2 is a lateral section view of the template illustrated in FIG. 1.
  • [0022]
    [0022]FIG. 3 is an illustration of an iontophoretic hydration device coupled to a template of FIG. 1.
  • [0023]
    [0023]FIG. 4 is an illustration of a hydraulic hydration device coupled to a template of FIG. 1.
  • [0024]
    [0024]FIG. 5 is a cut-away view of a skin surface with a hydrating template of FIG. 4 acting to hydrate the skin and subcutaneous layers.
  • [0025]
    [0025]FIG. 6 is a cut-away view of a skin surface and underlying tissue illustrating the ablation or altering of function of skin appendages.
  • [0026]
    [0026]FIG. 7 is an illustration of the secondary effects of collagen remodeling on skin appendages.
  • [0027]
    [0027]FIG. 8 is an illustration of ablation of a hair follicle as a result of collagen remodeling.
  • [0028]
    [0028]FIG. 9 is an illustration of an intracellular modification of a hair follicle resulting from collagen remodeling.
  • [0029]
    [0029]FIG. 10 is an illustration of hair growth in a hair follicle caused by intracellular modification from collagen remodeling.
  • [0030]
    [0030]FIG. 11 is a cut-away view of a skin surface that is being subjected to hydration and electromagnetic radiation, and illustrating the effect of hydration on impedance.
  • [0031]
    [0031]FIG. 12 illustrates intramolecular cross-linking of collagen.
  • [0032]
    [0032]FIG. 13 illustrates intermolecular cross-linking of collagen.
  • [0033]
    [0033]FIGS. 14 and 15 are two graphs illustrating a probability of collagen cleavage with changing bond strength at 37 degrees C.
  • [0034]
    [0034]FIG. 16 is a top down view of a skin surface, illustrating the peaks and valleys of the surface and the vectors applied to the surface by the application of a mechanical force.
  • [0035]
    [0035]FIG. 17 is a cross-sectional view of the skin surface illustrated in FIG. 16.
  • [0036]
    [0036]FIG. 18 is a cut-away view of the skin surface, with troughs and ridges, and underlying subcutaneous soft tissue.
  • [0037]
    [0037]FIG. 19(a) is a lateral perspective view of a telescoping segment of a breast expander useful with the apparatus of FIG. 1.
  • [0038]
    [0038]FIG. 19(b) is a front perspective view of the breast expander of FIG. 19(a).
  • [0039]
    [0039]FIG. 19(c) illustrates a bra which functions as the template of FIG. 1.
  • [0040]
    [0040]FIG. 19(d) is a lateral cross-sectional perspective view of a partially expanded breast expander within a breast.
  • [0041]
    [0041]FIG. 19(e) is a lateral cross-sectional perspective view of a fully expanded breast expander within a breast.
  • [0042]
    [0042]FIG. 20 illustrates a template in the form of a garment.
  • [0043]
    [0043]FIG. 21(a) illustrates a template that is positioned over a nose.
  • [0044]
    [0044]FIG. 21(b) illustrates a template that is positioned over an ear.
  • [0045]
    [0045]FIG. 22 is a perspective view of a template that is useful in the cervix.
  • [0046]
    [0046]FIG. 23 is a cross-sectional view of the template of FIG. 22.
  • [0047]
    [0047]FIG. 24(a) is a front view of an orthodontic appliance that includes RF electrodes.
  • [0048]
    [0048]FIG. 24(b) is perspective view of an orthodontic appliance template of the device of FIG. 1.
  • [0049]
    [0049]FIG. 24(c) is cross-sectional view of the template of FIG. 24(b)
  • [0050]
    [0050]FIG. 25 illustrates a template made of a semisolid material that becomes more conforming to underlying soft tissue upon the application of a mechanical force.
  • [0051]
    [0051]FIG. 26 illustrates a template with an adherent or suction mechanical force delivery surface that permits manual manipulation of skin and soft tissue structures.
  • [0052]
    [0052]FIG. 27 is a schematic diagram of an analog embodiment of the controller for use in the apparatus of FIG. 1.
  • [0053]
    [0053]FIGS. 28 through 31 represent a schematic block diagram of a microprocessor controlled impedance monitoring apparatus for controlling RF energy delivered by the apparatus of FIG. 1.
  • DETAILED DESCRIPTION
  • [0054]
    Referring now to FIGS. 1 and 2, an apparatus 10 modifies a skin surface or a soft tissue structure underlying the skin surface. A template 12 includes a soft tissue mechanical force application surface 14 and a receiving opening 16 to receive a body structure. Mechanical force application surface 14 is configured to receive the body structure and apply pressure to soft tissue in the body structure. An energy delivery device 18 is coupled to template 12. Energy delivery device 18 is configured to deliver sufficient energy to template 12 to form a template energy delivery surface 20 at an interior of template 12.
  • [0055]
    Mechanical force application surface 14 can apply pressure, suction, adhesion and the like in order to create an extension or compression of the soft tissue collagen containing structure and/or the skin surface.
  • [0056]
    Energy delivery device 18 and an energy source may be a single unit or each can be separate. Suitable energy sources 22 include but are not limited to the following: resistive heating, RF, coherent and incoherent light, microwave, electrical, thermal, magnetic, frictional heating, ultrasound, liquid thermal jet and cryogenic fluid energy sources. Energy delivery device 18 can form an energy delivery surface 20 in template 12 which can be the same size as mechanical force application surface 14.
  • [0057]
    Template 12 applies both a mechanical force and delivers energy to, (i) tighten the skin, (ii) smooth the surface of the skin, (iii) improve a compliance of the skin surface, (iv) improve a flexibility of the skin surface and (v) provide cellular remodeling of collagen in soft tissue anatomical structures. Mechanical force application surface 14, (i) is at least partially conforming to the skin surface, (ii) may apply a substantially even pressure to the soft tissue anatomical structures and (iii) can apply a variable pressure to the skin surface and underlying soft tissue structures. The combined delivery of electromagnetic energy and a mechanical force is used to create a three-dimensional contouring of the soft tissue structure. The amount of mechanical force applied by mechanical force application surface 14, (i) is sufficient to achieve a smoothing effect of the skin surface, (ii) can be less than the tensile strength of collagen in tissue and (iii) is sufficient to create vectors that cleave collagen cross-links to remodel collagen containing structures.
  • [0058]
    [0058]FIG. 3 illustrates apparatus 10 with an iontophoretic hydration device coupled to a template 12 in order to hydrate the target skin. Hydration of the skin is provided to convection cool and hydrate through a conductive semipermeability mobile membrane 13 of template 12 at surface 14. The hydration can be achieved with the delivery of a hydration medium from a reservoir 11 through the pores 15 of the membrane 13. The reservoir 11 can be coupled or de-coupled from template 12 by attaching or removing the reservoir connection tube 17. Permeability of the conductive semipermeability mobile membrane 13 can be altered by the development of an electrostatic or dielectric charge. Membrane permeability can also be altered by mechanically altering the thickness of the membrane, with or without tension. A change in membrane temperature also alters the permeability.
  • [0059]
    [0059]FIG. 4 illustrates another embodiment of apparatus 10 in which a hydraulic hydration device is coupled to a template 12 to hydrate the target skin. In this embodiment, hydraulic pressure can be used to vary the hydration rate. A hydraulic pressure gradient is produced and can be controlled by a feedback control system 28. The feedback control system 28 can receive inputs from a surface feedback sensor 21 that measures temperature or impedance, and/or a pressure sensor 25.
  • [0060]
    The semiporous membrane 13 dilates with the creation of a hydraulic pressure gradient. The hydraulic pressure applied can be no more than 300 mm Hg. The semiporous membrane 13 becomes more porous as the chamber 19 is inflated with hydrating solution, and as the membrane conforms to the skin in a repeating peak configuration. In this configuration, the porosity of the membrane 13 increases when hydraulic pressure in the chamber 19 increases. Hydraulic pressure is increased/maintained in the chamber 19 through the operation of the hydraulic pump 31 which is installed in series with the reservoir 11 and the chamber 19. The hydrating fluid is drawn from the reservoir 11 by the suction of the hydraulic pump 31 and the fluid is drawn through the reservoir connection tube 17 and enters the chamber 19 via the instillation channel 33.
  • [0061]
    The pressure in the chamber is variable and can be coupled to the feedback control system 28. The hydraulic damper 29, in conjunction with the collection bag 27 serves to increase or decrease the pressure in the chamber 19 by increasing or decreasing the restriction of hydrating fluid flow in accordance with signals supplied by the feedback control system 28. For instance, surface impedance measures the level of hydration. If the impedance is too low then the feedback control system 28 can act to either open damper 29 fully to decrease chamber 19 pressure and thus cease hydration, or convert to convection cooling. If the impedance is too high then a hydraulic pressure gradient can be produced to increase hydration by shutting damper 29.
  • [0062]
    A hydraulic hydration device may be incorporated with the remodeling apparatus 10 as shown in FIG. 4, or it may be used separately. It may also be used concurrently with remodeling apparatus 10 for surface convection cooling. The repeating peak configuration of the membrane 13 that is formed with the creation of a hydraulic gradient more effectively instills a sterile saline solution (or sterile water) with transcutaneous hydration. Each peak becomes more porous and represents an installation port. During hydration, hydraulic pressure is achieved by the cessation of flow due to the closing of damper 29, although the hydraulic pump 31 continues to function. Hydraulic pressure is modulated by a pressure sensor 25 instead of a flow sensor. However, a hydration sequence is initiated with an impedance backed sensor 21.
  • [0063]
    When hydration and remodeling are performed using separate devices, the surface 14 of the apparatus 10 can be smooth and non-porous. The membrane 13 of the hydration device must be prefabricated with the desired uniform peak configuration such that it becomes more porous with increasing hydraulic pressure. The hydraulic pressure gradient is created with a hydraulic pump 31 attached in series to a sterile solution. The gradient created may be continuous or pulsatile. This hydraulic/hydration device can also be used for the transcutaneous infusion of local anesthesia and/or medication.
  • [0064]
    As discussed, the hydraulic hydration device may be incorporated with the remodeling apparatus 10 for hydration and can also be used concurrently for convection surface cooling. The feedback control system 28 can utilize a flow damper algorithm to adjust the position of the damper 29 to regulate convection cooling based on surface 14 temperature and/or impedance. The temperature and/or impedance can be provided by a surface sensor 21. During hydration the damper 29 is closed and fluid flow ceases. For convection cooling, the damper 29 is open. In this manner, the device can provide a flow rate of a sterile solution for surface convection cooling that is modulated by a feedback surface temperature or impedance sensor 21.
  • [0065]
    As illustrated in FIG. 5, hydration is applied through the exterior of the skin and to selected areas of the skin. Additionally, the hydration medium can be delivered through the skin to collagen containing tissue. Hydration can be applied continuously, non-continuously, at one steady rate or at varied rates.
  • [0066]
    Hydration is monitored by impedance feedback, as more fully explained hereafter. RF energy delivery does not occur unless the surface impedance has dropped below a level that will not ablate or blister the skin surface. Initially, delivery of low level RF energy is performed to promote hydration and transcutaneous permeation of a local anesthetic. This is similar to an iontophoretic device. Following the achievement of anesthesia with a desired surface impedance, the treatment phase begins with the delivery of energy at a dose and dose rate that achieves contraction and remodeling of the matrix. In one embodiment, RF electrodes are used for the dual purpose of iontophoresis and collagen remodeling. Overall, apparatus 10 has multiple functions that are coupled with feedback control in a single geometry, i.e., energy delivery, conformance, convection cooling, hydration and topical anesthetic delivery. In another embodiment, separate devices with similar surface geometry are used for hydration and matrix remodeling.
  • [0067]
    Other than collagen remodeling, the application of a reverse thermal gradient with a conforming electromagnetic device can either ablate or alter the function of skin appendages such as hair follicles or sebaceous glands. Non-invasive hair removal through the ablation of the hair follicle is possible with a conforming electromagnetic device. This use is illustrated in FIG. 6. Dose and dose rate parameters of thermal energy, such as RF, are identified that will achieve hair removal while minimizing blistering of the skin surface. For this application, a deeper level of hydration is required as the base of the hair follicle (germinal epithelium) is sub-dermal. Injection of an impedance enhancing solution, such as glucose, into the follicle improves thermal release at the target structure. A higher dose rate with a small overall dose to the target and adjacent tissues is used for ablation of the hair follicle. A large energy dose to a small area of the hair follicle is delivered in a short period of time to minimize collateral damage to adjacent tissues.
  • [0068]
    Excessive sebum formation by the sebaceous gland is the major cause of an oily complexion. Excessive sebum formation may also be a precursor to acne vulgaris. A non-invasive reduction in sebum formation benefits patients with acne vulgaris. Medications, such as Acutane, have had partial success in reducing sebum formation but may have significant long term side effects, especially for young women during child bearing years.
  • [0069]
    As the sebaceous gland is intradermal, a reduction in the size of the structure can be achieved by contraction of the adjacent collagen matrix. Additionally, a partial ablation or intracellular suppression of sebum formation can be achieved with an energy delivery profile that is similar to that used in hair follicle ablation, i.e., high dose rate over short periods of time. A more superficial level of hydration is required as the sebaceous gland is located within the dermis. This is also illustrated in FIG. 6.
  • [0070]
    An additional clinical application is the ablation or intra-cellular modification of the sweat gland. The eccrine sweat gland has a thermal/regulatory function to maintain temperature homeostasis. The apocrine sweat gland is present in the axilla and perineal regions and is responsible for body odor. In addition, a disease condition of the apocrine sweat gland, hidradenitis suprativa, can result in the recurrent infection of the axillary and perineal regions. Suppression of the apocrine sweat gland will reduce body odor and may prevent either the development or recurrence of infections in the axillae and perineal regions. Excessive eccrine sweating may also be avoided especially in women with “hot flashes”. The subdermal and deeper dermal layers is the treatment zone for modification of sweating. This is achieved with a partial ablation of the apocrine sweat gland, in conjunction with a contraction of a sufficient amount of collagen containing tissue surrounding the apocrine sweat gland. Collagen contraction inhibits the physiology function of the apocrine sweat gland. This application is also illustrated in FIG. 6.
  • [0071]
    The application of a reverse thermal gradient with a conforming electromagnetic device can also be used for the treatment of dermal micro varicosities in a non-invasive manner. Hydration levels and dose rate/dose profiles are similar to the treatment of the overactive sebaceous gland. The contraction of the adjacent matrix around the micro varicosity diminishes the diameter of the structure. Non-invasive ablation of the varix is also possible with the manipulation of impedance with hydration and the selection of the appropriate dose rate/dose profile. This application is also illustrated in FIG. 6.
  • [0072]
    When the apparatus 10 is used for the primary purpose of contracting the collagen structure of a skin area there are corresponding secondary effects on skin appendages such as hair follicles, sebaceous glands, sweat glands, and dermal and subdermal capillaries for microvaricosity.
  • [0073]
    For instance, without ablation of the hair follicle, it may be possible to change the morphology of the hair from curly to straight and vice-versa. Hair color can also be modified in this manner with a reduction of melanin pigment produced in the hair follicle. This is achieved by intracellular modification of physiological function by contracting underlying collagen containing tissue surrounding the hair follicles. However, there is a direct effect of the electromagnetic energy with either ablation or intracellular modification in that it changes the physiological function of the skin appendages. This is illustrated in FIGS. 7, 8, 9, and 10.
  • [0074]
    Restoration of hair growth represents another important application that can be induced by electromagnetic radiation. Solar radiation has naturally modified intracellular function of skin over the millennia. The body's production of melanin by melanocytes to preserve hair and induce hair growth has responded to a specific frequency of the electromagnetic spectrum in the ultraviolet range. Thus, as solar radiation has modulated intracellular function over time, the damage has been mitigated by a physiological reaction.
  • [0075]
    In contrast, Keratin production in the skin by keratinocytes is less responsive to electromagnetic radiation than to mechanically applied energy. Frictional forces applied to the skin surface typically stimulate keratinocytic function. Callus formation is the morphological expression of this stimulation.
  • [0076]
    The hair follicle is comprised of melanocytes and keratinocytes in the germinal epithelium. The potential exists that the combination of mechanical force will incite keratin stimulation and that a specific frequency of electromagnetic radiation will induce pigment production. The net result is the growth of hair with a specific pigmentary pattern. Modern day medical devices that create specific vibrational frequencies can be coupled with electromagnetic sources that induce hair growth with a selected pigmentation.
  • [0077]
    In this application, delivery of electromagnetic radiation without surface ablation is facilitated with hydration. However, percolation without surface absorption of an impedance enhancing solution such as glucose into the hair follicle will direct the RF energy to this target skin appendage. For optical sources of energy, percolation of a nonabsorbent photodynamic dye into the hair follicle should provide similar benefits for ablation or modification of hair growth or hair color.
  • [0078]
    Referring back to FIG. 1, a sensor 21 is positioned at template energy delivery surface to monitor temperature, impedance and the like. Suitable sensors 21 include impedance and thermal devices. Sensor 21 is used to control the delivery of energy and reduce the chance of cell necrosis at the surface of the skin as well as damage to underlying soft tissue structures. Sensor 21 can also be used to provide input to the feedback control system 28 of a hydraulic hydration device. Sensor 21 is of conventional design, including but not limited to thermistors, thermocouples, resistive wires, and the like. A suitable thermal sensor 21 includes a T type thermocouple with copper constantene, J type, E type, K type, fiber optics, resistive wires, thermocouple IR detectors, and the like.
  • [0079]
    For most transcutaneous applications, the transmission of energy through the skin surface may function as a series impedance system. Increasing the extra-cellular fluid with hydration will decrease surface impedance and facilitate energy transfer through the skin without surface ablation. Subjacent non-hydrated dermal matrix will have a comparably higher impedance which is selectively heated and remodeled. This is illustrated in FIG. 11.
  • [0080]
    Hydration can be achieved with either extrinsic or intrinsic approaches. Extrinsic hydration is provided with either iontophoretic or hydraulic means. In addition to the reduction of surface impedance, extrinsic hydration provides the means to deliver medications, lotions or photodynamic dyes into the dermis. Installation of an optical dye into the dermis with a similar absorption spectrum of the incident optical source allows delivery of energy into the dermal collagen while reducing surface absorption. Accordingly, the peak absorption spectrum of the dye should be different than the absorption spectrum of the epidermis or the stratum corneum. The hydraulic device may have a conforming surface to provide a more uniform pattern of hydration.
  • [0081]
    Intrinsic hydration is achieved with either a conforming or non-conforming surface that is non-permeable or occlusive. A thermal energy source is coupled to and, and in one embodiment is incorporated in, the occlusive surface to facilitate hydration of the stratum corneum from the dermal ECF in a retrograde fashion. A reverse impedance gradient is created between the stratum corneum and the dermis, i.e., ECF content is raised in the stratum corneum and is lowered in the dermis. Surface impedance is measured and used as a feedback control device to determine an adequate amount of hydration to avoid surface ablation. The conforming intrinsic hydration device with a thermal energy source, including but not limited to RF, may not have a different end stage geometry than the treatment device in which hydration and collagen remodeling occurs concurrently. Intrinsic hydration also facilitates topical diffusion of medication, lotions, photodynamic therapy dyes, pharmacologic agents and the like.
  • [0082]
    Apparatus 10 is designed for the specific energy requirements of each type of bond within the collagen matrix. Collagen crosslinks may be either intramolecular (hydrogen bond) or intermolecular (covalent and ionic bonds). Hydrogen bonds are disrupted by heat. Covalent bonds may be cleaved with the stress created from the hydrogen bond disruption and the application of an external mechanical force. Cleavage of ionic bonds may be achieved with an alternating electrical moment in addition to the application of an external mechanical force that is applied by template 12. The strength of a hydrogen bond is relatively weak and can be thermally disrupted without ablation of tissue. The in vitro thermal cleavage of the hydrogen bond crosslinks of tropocollagen can result in the molecular contraction of the triple helix up to one third of its original length. However, in vivo collagen exists in fibrils that have extensive intermolecular crosslinks that are covalent or ionic. These covalent and ionic crosslinks are stronger and cannot be easily disrupted with heat. These intermolecular bonds are the main structural determinants of matrix strength and morphology. In vivo thermal disruption of intramolecular hydrogen bonds will not by itself result in a significant change in matrix morphology. As the intermolecular crosslinks are heat stable, cleavage may occur by a secondary mechanical process which can be the result of thermal disruption of intramolecular hydrogen bonds. In the non-polar region of the collagen fibril, intermolecular covalent bonds predominate (intramolecular covalent bonds are also present but are fewer in number).
  • [0083]
    These intermolecular covalent crosslinks increase with age, see FIGS. 12 and 13. As a result, the solubility of the collagen matrix in a soft tissue structure is reduced with this maturation process. Although tensile strength is increased, the collagen containing tissue becomes less compliant. Cleavage of an intermolecular bond requires approximately 1 ev of energy and can not be accomplished by heat without thermal ablation of tissue. In addition, covalent bonds are not strongly polar and will not be significantly affected by an RF current at this reduced power level. Cleavage of intermolecular covalent bonds that result in matrix remodeling without ablation is achieved by the stress created from the thermal disruption of intramolecular hydrogen bonds. Additional remodeling stress can be provided with the application of an external force that has the appropriate orientation to the fibrils of the matrix. Ionic bonds are essentially intermolecular and are present in the polar regions of the fibril. Although slightly weaker than covalent bonds, thermal disruption cannot occur without ablation of tissue. An RF field is an effective means to cleave these bonds and is created by an in phase alternating ionic motion of the extracellular fluid. Frequency modulation of the RF current may allow coupling to the ionic bonds in the polar regions of the fibril. Remodeling of a target site may be optimized by the selection of a band of the spectrum that is target site specific in order to reduce collateral damage. If an optimized intrinsic absorption is insufficient then a selective medium may be provided to alter the absorption in order to discriminate various soft tissue structures. This may be achieved by altering the absorption. By altering the extra-cellular fluid content of a soft tissue in specific ways, the delivery of energy to a target tissue site is achieved with minimal damage to collateral structures such as skin and adjacent soft tissue structures.
  • [0084]
    The reforming of bonds at the same bond sites will diminish the remodeling process. Relaxation phenomena may be inhibited with the application of an external mechanical force that separates bond sites but allows the reforming of these covalent and ionic bonds in a lengthened or contracted morphology. This can be the underlying biophysical process that occurs with the controlled remodeling of the collagen matrix. Ground substance may also function to diminish relaxation of crosslinks through competitive inhibition. Chondroitin sulfate is a highly charged molecule that is attached to a protein in a “bottle brush” configuration. This configuration promotes attachment at polar regions of the fibril and reduces the relaxation of ionic bonds in this region. As a consequence, immature soluble collagen, which has fewer intermolecular crosslinks and contains a higher concentration of ground substance, may be more easily remodeled. The induction of scar collagen through the wound healing sequence may also facilitate the remodeling process within a treatment area.
  • [0085]
    The cleavage of a collagen crosslink requires an energy threshold. However, collagen cleavage in tissue is a probability event. There is a greater probability that a collagen bond will be cleaved with higher temperatures. Cleavage of collagen bonds will occur at lower temperatures but at a lower frequency. Low level thermal cleavage is frequently associated with relaxation phenomena in which there is not a net change in molecular length. An external force that mechanically cleaves the fibril may reduce the probability of relaxation phenomena. The application of an external force will also provide a means to lengthen or contract the collagen matrix at lower temperatures while reducing the potential of surface ablation. The cleavage of crosslinks with collagen remodeling may be occurring at a basal metabolic temperature that is expressed morphologically as the process of aging. Although the probability for significant cleavage in a short period of time is small, aging may be expressed as a low level steady state of collagen remodeling with the external force of gravity that becomes very significant over a period of decades.
  • [0086]
    Hydrogen bonds which are relatively weak (0.2 ev to 0.4 ev) are formed within the tertiary structure of the tropocollagen molecule. Thermal disruption of these bonds can be achieved without ablation of tissue, i.e., cell necrosis. The probability of hydrogen bond disruption at a certain temperature can be predicted by statistical thermodynamics. If a Boltzmann distribution is used to calculate the probability of bond disruption then a graph illustrating the relationship between bond strength and the probability of bond disruption at a certain temperature can be produced. Graphs of the probability of cleavage at 37 degrees centigrade with various bond strengths are shown in FIGS. 14 and 15.
  • [0087]
    Different morphological expressions of aging may be due to the effect of gravity upon the matrix of a particular area. In areas of the skin envelope in which gravity lengthens the matrix, elastosis of skin will occur. In contrast to skin aging, certain anatomical structures such as joint ligaments will appear to tighten with the aging process. The reduced range of motion may be due in part to the vertical vector of gravity contracting the matrix of a vertically aligned ligament. However, most of the “tightening” or reduced range of motion of joints may not be secondary to a contracted matrix but is due to reduced flexibility of the matrix caused by increased intramolecular cross-linking that occurs with aging. Essentially, the controlled remodeling of collagen is the reversal of the aging process and involves the reduction in the number of intermolecular crosslinks. As a result the remodeled matrix becomes less brittle. Greater flexibility of the soft tissue has several functional advantages including an increased range of motion of component joints.
  • [0088]
    When the rate of thermal cleavage of intramolecular crosslinks exceeds the rate of relaxation (reforming of hydrogen bonds) then the contraction of the tertiary structure of the molecule can be achieved. No external force is required for this process to occur. Essentially, the contraction of the tertiary structure of the molecule creates the initial intermolecular vector of contraction. The application of an external mechanical force during thermal cleavage will also affect the length of the collagen fibril and is determined by the overall sum of intrinsic and extrinsic vectors that is applied during a cleavage event. Collagen fibrils in a matrix exhibit a variety of spatial orientations. The matrix is lengthened if the sum of all vectors act to distract the fibril. Contraction of the matrix is facilitated if the sum of all extrinsic vectors acts to shorten the fibril. Thermal disruption of intramolecular bonds and mechanical cleavage of intermolecular crosslinks is also affected by relaxation events that restore preexisting configurations. However, a permanent change of molecular length will occur if crosslinks are reformed after lengthening or contraction of the collagen fibril. The continuous application of an external mechanical force will increase the probability of crosslinks forming after lengthening or contraction of the fibril.
  • [0089]
    The amount of (intramolecular) hydrogen bond cleavage required will be determined by the combined ionic and covalent intermolecular bond strengths within the collagen fibril. Until this threshold is reached little or no change in the quaternary structure of the collagen fibril will occur. When the intermolecular stress is adequate, cleavage of the ionic and covalent bonds will occur. Typically, the intermolecular cleavage of ionic and covalent bonds will occur with a ratcheting effect from the realignment of polar and non-polar regions in the lengthened or contracted fibril. Birefringence (as seen with the electron microscope) of the collagen fibril may be altered but not lost with this remodeling process. The quarter staggered configuration of the tropocollagen molecules in the native fiber exhibits a 680 Å banding which either lengthens or contracts depending on the clinical application.
  • [0090]
    Application of the mechanical force with template 12 during the remodeling process determines if a lengthened or contracted morphology of the collagen fibril is created. An external force of contraction will result in the contraction of the tertiary and quaternary structure of the matrix. With the application of an external distraction force, intramolecular contraction may still occur from the intrinsic vector that is inherent within its tertiary structure. However, overall lengthening of the quaternary structure of the fibril will occur due to the mechanical cleavage of the intermolecular bonds. Contraction of the tertiary structure with overall lengthening of the collagen fibril can alter the birefringence of the matrix. The altered periodicity will be exhibited in the remodeled matrix that will correlate to the amount of lengthening achieved.
  • [0091]
    Delivery of both electromagnetic energy and mechanical energy to the selected body structure involves both molecular and cellular remodeling of collagen containing tissues. The use of low level thermal treatments over several days provides an additional way to contract skin with minimal blistering and cell necrosis. Cellular contraction involves the initiation of an inflammatory/wound healing sequence that is perpetuated over several weeks with sequential and lengthy low level thermal treatments. Contraction of skin is achieved through fibroblastic multiplication and contraction with the deposition of a static supporting matrix of nascent scar collagen. This cellular contraction process is a biological threshold event initiated by the degranulation of the mast cell that releases histamine. This histamine release initiates the inflammatory wound healing sequence.
  • [0092]
    Molecular contraction of collagen is a more immediate biophysical process that occurs most efficiently with electromagnetic energy delivery devices, including but not limited to RF electrodes. The clinical setting is physician controlled and requires more precise temperature, impedance, and energy delivery monitoring to avoid blistering of the skin. Measured impedance will vary with the frequency of the electromagnetic energy applied to the skin surface and/or underlying soft tissue structure. Continuous monitoring of impedance is used to measure the amount of skin surface hydration that is required for the transcutaneous delivery of electromagnetic energy. Monitoring of surface temperature for water content of the skin surface is important for thermal energy sources, i.e., when thermal conductivity is enhanced with hydration.
  • [0093]
    Patients may be treated with one or both modalities to achieve the optimal esthetic result. Refinements to the treatment area may be required using apparatus 10 in the physician's office.
  • [0094]
    However, tightening of a skin surface without application of external compression may accentuate any preexisting contour irregularities. For this reason, conforming esthetic template 12 is used to smooth surface contour irregularities. Essentially, the application of a mechanical force upon the collagen matrix involves both contraction or distraction of the selected soft tissue structure to achieve a smoother contour. Thermal (or em) cleavage of collagen crosslinks when combined with a mechanical force creates vectors that contract, distract or shear the longitudinal axis of the fibril. A vector space is created with the combination of a scalar component (heat) and a vector (an externally applied mechanical force). The vectors within this vector space vary depending upon the specific morphology. For example, the peaks and valleys of cellulite will have different vectors when uniform external compression is applied. As illustrated in FIGS. 16 and 17, template 12 produces converging and diverging vectors that smooth surface morphology by contracting (valleys) and distracting (peaks) the collagen matrix in a soft tissue structure. Diverging vectors on the peaks lengthen the collagen matrix while converging vectors in the valleys contract and compact the collagen matrix. The overall result is the smoothing of an irregular skin surface.
  • [0095]
    Apparatus 10 may also be used to treat wrinkling of the skin. The treatment of skin wrinkles is shown in FIG. 18. In a skin wrinkle the vectors are directed perpendicular to the troughs and ridges of this contour deformity. Diverging vectors at the ridges of the skin converge in the trough of the wrinkle to smooth the surface morphology . The collagen matrix is distracted or extended at the ridges and contracted in the valleys. The overall result is the smoothing of the wrinkled skin surface.
  • [0096]
    Linear scars exhibit a similar morphology and can be remodeled with apparatus 10. Any surface irregularity with depressions and elevations will have vectors directed to the lowest point of the deformity. Prominent “pores” or acne scaring of the skin have a similar pattern to cellulite but on a smaller scale and can also be treated with apparatus 10. Clinically, the application of the mechanical force reduces the power required to remodel the matrix and diminishes cell necrosis of the skin surface as well as underlying soft tissue structures. Compression alters the extracellular fluid of the soft tissue structure (collagen) and exerts electrical impedance and thermal conductivity effects that allow delineation of a conduit-treatment interface of the collagen containing tissues. A deeper dermal interface will contract skin and exert three dimensional contour effects while a more superficial interface will smooth surface morphology.
  • [0097]
    In circumstances in which expansion of the skin envelope is needed, the combined application of heat and pressure is also required. For breast reconstruction, expansion of the skin envelope is typically achieved with each inflation of a subpectoral breast expander. FIGS. 19(a) and 19(b) illustrate an expander with an RF receiver electrode. A telescoping segment with an RF energy source is incorporated with access valve and is used to expand a nipple areolar donor site for Pectoralis “Peg” Procedure. The segmental expander can also be used to prepare the recipient site for delayed autologous “Peg” Flap. The pressure that is exerted on the skin and the periprosthetic scar capsule is from the inside. In this application, vectors are directed outward. As an adjunct to this expansion process, a controlled thermal pad may be incorporated into a bra, as illustrated in FIG. 19(c), which can be applied to the inferior pole of the breast skin to promote lengthening of collagen fibril within the skin and underlying scar capsule around the expander. The bra may also function as an external conforming template 12 to achieve a specific breast shape. The net result is the creation of a more esthetic breast reconstruction with three dimensional characteristics of the opposite breast. In a like manner, other garments with incorporated thermal energy sources can be utilized as external conforming templates for other anatomical body structures.
  • [0098]
    In FIG. 19(d) a breast expander is partially expanded within the breast. In FIG. 19(e), the expander is fully expanded within the breast.
  • [0099]
    Template 12 applies a mechanical force in combination with the delivery of energy, with minimal cell necrosis to the skin surface and underlying soft tissue structure, to remodel collagen both esthetically and functionally. Template 12 can be in a variety of different forms including but not limited to a garment that is illustrated in FIG. 20. Energy source 22 can be directly incorporated into the fabric of a tight fitting garment or inserted as a heating/RF pad into a pocket of the garment. Another example of a garment is a tight fitting bra that extends over the arm and waistline with zone control that provides contraction of the skin of the breast, arms, and waistline to a variable amount to create a desired three-dimensional figure. Functional remodeling of collagen containing structures include a variety of different applications for aesthetic remodeling.
  • [0100]
    As shown in FIGS. 21(a) and 21(b), template 12 can be a garment positioned over the nose, a garment positioned around the ear, and the like.
  • [0101]
    Template 12 can also be applied for functional purposes. Referring now to FIGS. 22 and 23, pre-term cervical dilation can be treated with a template 12 that is the impression “competent” cervix. The cervical template 12 create vectors that contract the circumference of the cervix. The incorporated energy delivery device 18 contracts the native matrix and induces scar collagen. The dilated cervical OS is tightened and the entire cervix is strengthened. Energy delivery device 18 can be incorporated into template 12 which can be the cervical conformer and inserted as a vaginal obturator. It will be appreciated that template 12 can be utilized for other functional treatments.
  • [0102]
    In another embodiment, template 12 is a functional appliance that may be non conforming and can be separate or incorporated with the energy delivery device 18. Orthodontic braces that are designed with energy delivery device 18 are used to remodel the collagen of the periodontal ligament and apply rotation and inclination vectors on the tooth. In FIG. 24(a) orthodontic braces are coupled to RF electrodes and associated power source. The orthodontic braces function as a non-conforming force application surface that is coupled to incorporated RF electrodes. FIGS. 24(b) and 24(c) illustrates a orthodontic appliance that is a conforming template 12 coupled to RF electrodes. As a consequence, orthodontic correction is more rapidly achieved than current modalities that employ only mechanical forces. Orthodontic correction can also be achieved with a conforming template 12 that is the corrected impression of the patient's dentition.
  • [0103]
    For orthopedic applications, an external fixation device is used as a non conforming functional appliance. This appliance is used in tandem with an energy source device, including but not limited to RF electrodes, that remodels the collagen of the callus tissue. More accurate alignment of osteotomy and fracture sites are possible with either a conforming or nonconforming brace that is used in tandem or is directly incorporated into energy delivery device 18. Improved range of motion of contracted joints and correction of postural (spinal) deformities can be achieved with this combined approach.
  • [0104]
    The ability to remodel soft tissue in anatomical structures other than skin is dependent upon the presence of preexisting native collagen. Induction of scar collagen is performed in tissue devoid or deficient of native collagen.
  • [0105]
    Template 12 can be used to remodel the subcutaneous fat of hips and thighs in addition to the tightening of the skin envelope. The convolutions of the ear cartilage can be altered to correct a congenital prominence. The nasal tip can be conformed to a more esthetically pleasing contour without surgery.
  • [0106]
    Another application of the conforming energy delivery device involves the noninvasive ablation of subcutaneous fat with contraction of the overlying skin envelope. Altering the energy delivery parameter (dose rate/dose) of the device provides a means to concomitantly reduce contour with the ablation of fat while contraction and conforming the overlying skin envelope to a more aesthetic contour. Ablation of the subcutaneous fat is achieved with a higher dose rate than collagen remodeling of the skin. Various energy sources can be used including but not limited to ultrasound, RF, incoherent and coherent light and thermal.
  • [0107]
    The combined ablation/remodeling application is facilitated with surface hydration and the injection of an impedance altering solution into the subcutaneous fat. The addition of Xylocaine and Wydase into this (tumescent) solution provides anesthesia while lowering the Ts (collagen shrinkage temperature) of the dermis and fibrous septae.
  • [0108]
    Although various non-conforming ultrasonic devices can noninvasively ablate fat, morphological outcomes are completely different than outcomes achieved with conforming devices. Contour reduction achieved with nonconforming devices may aggravate pre-existing surface irregularities because skin contraction does not occur. The apparatus 10 of the present invention, which may or may not be coupled to a hydration device, reduces contour with fat ablation while tightening the skin envelope in a noninvasive manner.
  • [0109]
    Template 12 can be used with any modality that remodels collagen. In addition to RF (molecular) remodeling of collagen, cellular modalities that invoke the wound healing sequence can be combined with a conforming esthetic template. Thermal and chemical sources (glycolic acid) induce a low level inflammatory reaction of the skin. Scar collagen induction and fibroblastic (cellular) contraction are directed into converging and diverging vectors by a conformer that produces a smoother and tighter skin envelope. In addition to achieving a smoother and tighter integument, the texture of the skin is also improved with this remodeling process. Older or less compliant skin has a greater number of intermolecular crosslinks in the dermal collagen than younger skin. Scar collagen induction with cleavage of crosslinks will produce a softer and more compliant skin envelope.
  • [0110]
    Referring now to FIGS. 25 and 26, template 12 can be stationary or mobile. A hand held conforming template 12 that is mobile provides the practitioner with greater flexibility to remodel the collagen matrix. Pressure and impedance changes can serve as a guide for the manual application of template 12. A hand held template 12 with an incorporated energy source may be applied over a conductive garment that provides additional three dimensional conformance to the treatment area. The occlusive geometry of template 12 enhances hydration and reduces impedance. Less accessible areas can be remodeled with this particular device. Template 12 of FIG. 25 may be made of a semi-solid material 35 that conforms a lax skin envelope to an underlying soft tissue structure. The semi-solid material customizes the creation of force application surface 14 and reduces the need for precise fabrication of an esthetic template. Suitable semi-solid materials include soft plastics that are thermally and electrically conductive. Additionally, the semi-solid material is semipermeable to provide hydration. The permeability of the material can be altered electrically or mechanically. For example, in one embodiment, the application of an electrostatic charge through the material will alter permeability. In another embodiment, externally applied compression will increase permeability of the contact surface material.
  • [0111]
    Controlled remodeling of collagen containing tissue requires an electromagnetic device that lengthens or contracts the matrix with a minimum of cell necrosis. Energy delivery device 18 can include a plurality of RF electrodes with or without insulation. The non-insulated sections of the RF electrodes collectively form template energy delivery surface 20. In a similar manner, microwave antennas, optical waveguides, ultrasound transducers and energy delivery or energy remove fluids are used to form template energy delivery surface 20. Individual electrodes and the like can be multiplexed and to provide selectable delivery of energy.
  • [0112]
    Template 12 delivers both electromagnetic energy and mechanical energy to the selected body structure. Suitable body structures include but are not limited to, hips, buttocks, thighs, calves, knees, angles, feet, perineum, the abdomen, chest, back flanks, waistline, legs, arms, legs, arms, wrists, upper arms, axilla, elbows, eyelids, face, neck, ears, nose, lips, checks, forehead, hands, breasts and the like.
  • [0113]
    A variety of different mechanical forces can be applied to tissue including but not limited to, (i) pressure, (ii) expansion, (iii) stretching, (iv) extension, (v) prolongation, (vi) lengthening or (vii) shearing. The pressure force can be a positive pressure or a negative pressure. Positive pressure provides a compression of collagen containing tissue, with converging and diverging vectors, and negative pressure creates an extension of collagen containing tissue with converging and diverging vectors.
  • [0114]
    The duration and measurement of skin surface impedance provides a delineation of a preferred treatment level within the dermis. Surface impedance monitoring is used to determine the amount of surface hydration that reduces ablation with the passage of electromagnetic energy. However, impedance monitoring can also be used to determine a preferred dermal level of treatment. More superficial dermal treatment levels are used to treat wrinkles. Deeper dermal levels are delineated for skin contraction and three-dimensional conformance.
  • [0115]
    In various embodiments, energy delivery device 18 provides a controlled delivery of electromagnetic energy to the skin surface that does not exceed, 1,000 joules/cm2, or 10 joules/sec/cm2; provides a controlled delivery of not exceeding 600 joules/cm2 during a single treatment session (during a twenty-four hour period), operates in an impedance range at the skin surface, provides a controlled delivery not exceeding 200 joules/cm2 during a single treatment session, or not exceeding 10 joules/sec/cm2; operates in an impedance range at the skin surface of, 70 ohms cm2 measured at a frequency of 88 Hz to 40 Kohms cm2 measured at a frequency of 10 KHz; provides a controlled delivery of electromagnetic energy to operate in a range of thermal conductivity at a skin surface of 0.21 to 0.60 k; operates in a range of compression force applied to the skin surface and/or the underlying soft tissue anatomical structure not exceeding 400 mmHg, not exceeding 300 mm, not exceeding 200 mmHg or not exceeding 100 mmHg.
  • [0116]
    To minimize and/or avoid surface ablation, saturation of the stratum corneum, epidermis and conduit matrix is required. Surface hydration with a measured impedance down to 70 ohms at a frequency of 88 Hz is achieved. Target collagen containing tissues will exhibit a higher than altered impedance that can be further increased with the application of external compression.
  • [0117]
    [0117]FIG. 27 illustrates a schematic block diagram of an analog embodiment of a specific impedance monitoring device 24 that can be used with apparatus 10 and be incorporated into a feedback control system. Impedance monitoring device 24 is used to control the delivery of electromagnetic and mechanical energy to the skin surface and underlying soft tissue structure to minimize, and even eliminate, cell necrosis as well as blistering of the skin surface. Impedance monitoring device 24 monitors other parameters including but not limited to: if there is an open circuit, if there is a short circuit, or if voltage and current is supplied to the tissue for more than a predetermined maximum amount of time. Such conditions may indicate a problem with apparatus 10 . When energy delivery device 18 is one or more RF electrodes, a generator 26 supplies RF energy to the energy delivery surface 20. Generator 26 is turned on by a user operated switch 37 which provides a signal to controller 35 to turn activate the generator 26. An output 30 of controller 35 is coupled to an analog switch 32. When output 30 provides an “RF on” signal to the switch 32 an oscillator 34 coupled to an analog multiplier 36 through switch 32, supplies a voltage of a known frequency to analog multiplier 36. An output of analog multiplier 36 is coupled to a driver 38 which is coupled to the input of an RF amplifier 40. The output of RF amplifier 40 is coupled to circuit 42.
  • [0118]
    Current and voltage delivered to tissue is measured and an RMS current (“I sub RMS”) and an RMS voltage (“V sub RMS”) are determined. A voltage and current sensor 44 senses the current and voltage delivered to tissue. Voltage and current sensor 44 includes a low impedance current transformer 46 in series with generator 26 and a high impedance voltage transformer 48 connected in parallel across generator 26. Current transformer 46 may have a 1:20 winding ratio and a 50 ohm resistor in parallel with a secondary of low impedance current transformer 46. Voltage transformer 48 may have a 20:1 winding ratio and a 1K ohm resistor in parallel with the secondary of high impedance voltage transformer 48.
  • [0119]
    The output of low impedance current transformer 46 is coupled to an RMS converter 50. RMS converter 50 converts a sensed current to a DC signal to provide output 52, representative of I sub RMS. The output of voltage transformer 48 is coupled to an RMS converter 54. RMS converter 54 converts the voltage signal into an DC signal to provide output 56, representative of V sub RMS.
  • [0120]
    The measured impedance, Z, is then calculated from the measured I sub RMS and V sub RMS. Outputs 56 and 52 (V sub RMS and I sub RMS) are supplied to an analog divider 58 which divides the V sub RMS by the current I sub RMS to provide an output signal 60 representative of the measured impedance Z.
  • [0121]
    From the I sub RMS, V sub RMS and measured impedance Z, impedance monitoring circuit 24 determines whether, (i) a short circuit or open circuit condition exists, (ii) voltage and current has been delivered for an amount of time exceeding a predetermined maximum and (iii) whether controlled remodeling, contraction, tightening, smoothing and the like is complete.
  • [0122]
    A short circuit condition is determined by comparing measured impedance Z to a predetermined short circuit impedance threshold at or below which short circuit is likely to exist (“Z sub SC”). If the measured Z is at or below the Z sub SC, a short circuit signal is provided to controller 35.
  • [0123]
    Impedance signal 60 is input to a short circuit detector 62 comprised of a comparator 70. A positive input 64 of the comparator 70 is connected to a potentiometer 66 which sets the threshold impedance, Z sub SC. When impedance signal 60 causes the input at a negative input 68 of a comparator 70 to be lower than that at positive input 64, an “on” condition occurs at an output 72 of comparator 70. This condition is communicated to controller 35 which provides a preprogrammed response that can include turning off RF energy.
  • [0124]
    A current threshold detector 74 includes a potentiometer 76 coupled to a negative input 78. Potentiometer 76 sets the I sub thresh level so that when a current is present, current detector 74 will indicate as such. The I sub RMS signal 52 is connected to a positive input 80 of current threshold detector 74. Thus, when the I sub RMS signal is greater than the value, I sub thresh, set by the potentiometer 76, a positive voltage appears at an output 81 of current threshold detector 74.
  • [0125]
    Similarly, a voltage threshold detector 82 includes a potentiometer 84 connected to a negative input 86. Potentiometer 84 sets the voltage threshold at which threshold detector 82 registers a positive output, V sub thresh, when a minimum voltage is present. The V sub RMS signal 56 is input to a positive input 88 of the threshold detector 82. If V sub RMS exceeds V sub thresh set by potentiometer 84 a positive voltage appears at an output 90 of voltage threshold detector 82.
  • [0126]
    Output 90 of the voltage threshold detector 82 is coupled to an input 91 of AND gate 92 and the output 81 of current threshold detector 74 is coupled to an inverted input 94 of AND gate 92. AND gate 92 acts as an open circuit detector. When V sub RMS exceeds V sub thresh and where the I sub RMS does not exceed I sub thresh, a logic 1(not shown) will appear at an output 96 of AND gate 92 indicating an open circuit. Output 96 of AND gate 92 is coupled to controller 35 to communicate the open circuit status.
  • [0127]
    The output 81 of current threshold detector 74 is also coupled to an OR gate 98 which is coupled to a timer 100. If I sub RMS exceeds I sub thresh, the output 81 of current threshold detector 74 will present a logic 1 to the OR gate 98, causing the OR gate output 102 to be high (logic 1) and turning on timer 100.
  • [0128]
    Similarly, output 90 of voltage threshold detector 82 is coupled to OR gate 98. If V sub thresh is exceeded by V sub RMS, the output 90 of voltage threshold detector 82 will present a logic 1 to the OR gate 98, causing the OR gate output 102 to be high (logic 1) and turning on timer 100.
  • [0129]
    An output 104 of timer 100 is coupled to controller 35. When timer 100 has been activated for an amount of time that exceeds a preset threshold time, T sub max, output 104 will be a logic 1. Timer 100 is reset with a user activated switch that is coupled to the timer reset input 106, when apparatus 10 is reset.
  • [0130]
    A continuous comparison is made between Z and f(Z sub min). It should be noted here that f(Z sub min) is continuously calculated as f(Z) until a Z sub min is detected. The comparison is continuously made between Z and f(Z) until Z sub min is determined.
  • [0131]
    If measured Z is less than or equal to the Z sub target then RF energy is continued to be supplied and steps described above are carried out until a signal has been provided to controller 35 that there is an open circuit signal, short circuit signal or a time over signal. If the measured Z is greater than or is equal to “Z sub target” then a signal is provided to controller 35. It is noted that in this embodiment, Z has been inverted and shifted in order to accommodate Z sub min determination.
  • [0132]
    A control device which controls an RF generator energy output based on load impedance. The load impedance is used to determine a preferred energy level, e.g., voltage, current or power level, based on a specific system load curve for generator 26, other power sources and/or application, as well as controlling the delivery of the hydration medium from hydration medium source 11. The control device then compares the actual energy level for measured impedance with the desired energy level and adjusts the generator output according to the difference between the two, i.e., preferably to minimize the difference between the two. A gradient of tissue impedance is achieved that relates to the clinical application. Superficial applications, including but not limited to wrinkle treatment, will have a higher relative surface impedance than deeper skin contraction applications which will have a lower measured surface impedance.
  • [0133]
    The specific load curve preferably reflects the voltage, current, power, for a range of impedance that will optimize performance of apparatus 10 for a variety of different procedures and anatomical body structures. The load curve may have various forms, for example, it may be continuous or may be stepped. The load curve may vary from power source to power source, or for different body structures and/or applications. In a one embodiment using apparatus 10, different impedance ranges may be identified at which different energy requirements exist. Initially tissue impedance is in a lower range. In the lower ranges more current is required to provide enough power. A second, mid-range of impedances requires enough power to maintain the process. A third range of higher impedances may be required at the end of the process.
  • [0134]
    In one embodiment, impedance is monitored to measure the amount of skin surface hydration that is required for the transcutaneous delivery of RF energy as well as other electromagnetic energy delivered to the collagen containing tissue.
  • [0135]
    Referring now to FIGS. 28 through 31 a flow chart illustrates a method for carrying out a microprocessor controlled embodiment of the present invention. When the system is turned on (block 200), the variables including Z sub min, V sub thresh, I sub thresh, time over, and Z sub initial, are initialized (block 201). The system continues to look for the activation of the RF switch (block 202). When the RF switch is turned on, the interrupts are set for RF Switch (block 203), for Short Circuit (block 204), and Open Circuit (block 205) so that when one of these interrupt conditions occur, the microprocessor automatically goes to the instructions associated with block 234.
  • [0136]
    After the interrupts are set, the timer is started (block 206). A sequence is run to check the RF amplifier health (block 207), e.g., to look for an Amplifier On signal or to check if certain voltages are in a suitable range. If the amplifier is operating properly, RF energy is turned on (blocks 208 and 209).
  • [0137]
    If the amplifier is not operating correctly, an RF Off request is made (blocks 209 and 210) and a Hardware Failure Alert flag is set (block 211). The system looks for a hardware failure flag (block 233). When the hardware failure is detected, the controller provides a hardware failure alert indication and shuts off. (blocks 243 and 244).
  • [0138]
    If hardware failure is not indicated (block 233), then V sub rms and I sub rms is read (block 235) to determine if any voltage or current is being supplied by the system (block 236). When the system is first initialized, until the instruction to turn on energy in block 209 is reached, there should be no current or voltage. If there is a voltage or current with the RF request off, then there is a hardware failure. A hardware failure alert is indicated and the program is stopped (blocks 243 and 244).
  • [0139]
    If RF energy is turned on (block 209), then the V sub rms and I sub rms are read and the impedance, Z, is calculated by dividing the V sub rms by the I sub rms. (block 212). The controller checks to see if the V sub enable and 1 sub enable flags are set. (block 213). These flags are set when a minimum threshold voltage is present and a minimum threshold current is delivered through the electrodes of the device. (blocks 214, 215, 216, and 217).
  • [0140]
    If the V sub enable and 1 sub enable flags are set (213) the software looks for a time over condition to determine if the device has been on for a period of time in excess of a maximum. If a time over condition is recognized, the timer flag is set, RF energy is turned off (blocks 218 and 219) and a hardware failure check is run (block 233).
  • [0141]
    After looking for a time over condition, the controller checks for a short circuit or open circuit condition. If a short or open circuit exists, the corresponding short circuit or open circuit bit is set (block 220), RF energy is turned off (block 221), and a hardware failure check is run (block 233).
  • [0142]
    The controller checks again for V sub enable and I sub enable in block 222, before proceeding to the threshold determining portion of the circuit illustrated in FIG. 27. If the voltage or current did not exceed V sub thresh or I sub thresh in blocks 214 and 216, the controller iterates the sequence beginning at block 212 for detecting time over, short circuit, open circuit, i.e., the coagulation complete detection enable. This enables the device to wait until enough current and voltage is delivered to the circuit to check for the coagulation complete condition.
  • [0143]
    If the V sub enable and 1 sub enable flags are set, the short circuit and open circuit bits are not set (block 220), and the time over condition does not yet exist (block 219), the measured impedance used to determine completion of matrix remodeling is as follows. Remodeling of the matrix into a more compact configuration will alter the ECF/hydration which will be measured as an increase of impedance. Desiccation of the matrix is avoided by ceasing the delivery of electromagnetic radiation when the impedance is above the allowed range.
  • [0144]
    The Z initial flag is set during the first iteration and Z sub min is initially assigned the measured impedance value (blocks 223-225). Initially, Z sub min is the same as the measured impedance and thus block 227 is bypassed at block 226. A calculation is made of f(Z sub min) (block 228). As long as the measured impedance is less than the f(Z sub min), the sequence is iterated (229, 231). In the next iteration of blocks 223-231, the newly measured impedance is compared to the previous measured impedance which has been assigned Z sub min (block 226). As long as the impedance is decreasing, Z sub min will be reassigned the new value of the measured impedance (blocks 226 and 227) and the steps repeated. When the measured impedance is greater than or equal to f(Z sub min), i.e. the threshold impedance, the coagulation complete flag is set (block 230). If coagulation complete flag is set, the RF is turned off (block 232) and the hardware failure check is run.
  • [0145]
    If after the initial run through the program a hardware failure alert occurs (block 233, 236) or an interrupt occurs, the program determines the cause and indicates as such (blocks 233-242). The V sub rms and I sub rms are read, (block 235). If no current or voltage is being delivered to the system, the controller checks to see if the open circuit, short circuit or time over flags have been set (block 237). If so then a signal indicates which flags have been set, and the program is returned to start (blocks 240, 242). Similarly, the controller checks for the coagulation complete flag (block 239). If there was the coagulation complete flag has been set, it will be indicated for ten seconds (block 241). If not, it will be indicated as not complete (block 240) and the program will return to point at the start (block 242). Preferably the electrical components selected to carry out the steps of FIGS. 28 through 31 are adapted to provide a complete iteration of all the steps at least every 1/50 second.
  • [0146]
    The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7630774 *Mar 17, 2005Dec 8, 2009Alma Lasers Ltd.System and method for heating biological tissue via RF energy
US7854754 *Feb 22, 2006Dec 21, 2010Zeltiq Aesthetics, Inc.Cooling device for removing heat from subcutaneous lipid-rich cells
US7945321 *Apr 20, 2009May 17, 2011Mattioli Engineering Ltd.Method and apparatus for skin absorption enhancement and transdermal drug delivery
US8073550Aug 14, 2000Dec 6, 2011Miramar Labs, Inc.Method and apparatus for treating subcutaneous histological features
US8166332Jul 24, 2009Apr 24, 2012Ardent Sound, Inc.Treatment system for enhancing safety of computer peripheral for use with medical devices by isolating host AC power
US8192474Nov 9, 2006Jun 5, 2012Zeltiq Aesthetics, Inc.Tissue treatment methods
US8235909May 11, 2005Aug 7, 2012Guided Therapy Systems, L.L.C.Method and system for controlled scanning, imaging and/or therapy
US8246611 *Jun 14, 2007Aug 21, 2012Candela CorporationTreatment of skin by spatial modulation of thermal heating
US8275442Sep 23, 2009Sep 25, 2012Zeltiq Aesthetics, Inc.Treatment planning systems and methods for body contouring applications
US8282554 *Apr 11, 2012Oct 9, 2012Guided Therapy Systems, LlcMethods for treatment of sweat glands
US8285390Aug 21, 2008Oct 9, 2012Zeltiq Aesthetics, Inc.Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US8291913Aug 18, 2008Oct 23, 2012Reliant Technologies, Inc.Adaptive control of optical pulses for laser medicine
US8333700 *Sep 4, 2012Dec 18, 2012Guided Therapy Systems, L.L.C.Methods for treatment of hyperhidrosis
US8337539Nov 9, 2010Dec 25, 2012Zeltiq Aesthetics, Inc.Cooling device for removing heat from subcutaneous lipid-rich cells
US8366622Apr 11, 2012Feb 5, 2013Guided Therapy Systems, LlcTreatment of sub-dermal regions for cosmetic effects
US8398621Nov 14, 2007Mar 19, 2013Braun GmbhDevice for treating the skin
US8409097Mar 24, 2011Apr 2, 2013Ardent Sound, IncVisual imaging system for ultrasonic probe
US8444562Jun 12, 2012May 21, 2013Guided Therapy Systems, LlcSystem and method for treating muscle, tendon, ligament and cartilage tissue
US8460193Jun 3, 2010Jun 11, 2013Guided Therapy Systems LlcSystem and method for ultra-high frequency ultrasound treatment
US8480585May 4, 2007Jul 9, 2013Guided Therapy Systems, LlcImaging, therapy and temperature monitoring ultrasonic system and method
US8506486Nov 16, 2012Aug 13, 2013Guided Therapy Systems, LlcUltrasound treatment of sub-dermal tissue for cosmetic effects
US8523775 *Sep 4, 2012Sep 3, 2013Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US8523927Jul 13, 2007Sep 3, 2013Zeltiq Aesthetics, Inc.System for treating lipid-rich regions
US8535228Feb 8, 2008Sep 17, 2013Guided Therapy Systems, LlcMethod and system for noninvasive face lifts and deep tissue tightening
US8603073Dec 17, 2008Dec 10, 2013Zeltiq Aesthetics, Inc.Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US8623002Jul 20, 2004Jan 7, 2014Koninklijke Philips N.V.Electromagnetic radiation delivery apparatus
US8636665Mar 7, 2013Jan 28, 2014Guided Therapy Systems, LlcMethod and system for ultrasound treatment of fat
US8641622Sep 12, 2011Feb 4, 2014Guided Therapy Systems, LlcMethod and system for treating photoaged tissue
US8663112Dec 23, 2009Mar 4, 2014Guided Therapy Systems, LlcMethods and systems for fat reduction and/or cellulite treatment
US8672848Jan 23, 2012Mar 18, 2014Guided Therapy Systems, LlcMethod and system for treating cellulite
US8676338Jul 20, 2010Mar 18, 2014Zeltiq Aesthetics, Inc.Combined modality treatment systems, methods and apparatus for body contouring applications
US8690778Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcEnergy-based tissue tightening
US8690779Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcNoninvasive aesthetic treatment for tightening tissue
US8690780Jun 21, 2013Apr 8, 2014Guided Therapy Systems, LlcNoninvasive tissue tightening for cosmetic effects
US8702774Apr 30, 2010Apr 22, 2014Zeltiq Aesthetics, Inc.Device, system and method of removing heat from subcutaneous lipid-rich cells
US8708935Jul 12, 2010Apr 29, 2014Guided Therapy Systems, LlcSystem and method for variable depth ultrasound treatment
US8715186Nov 24, 2010May 6, 2014Guided Therapy Systems, LlcMethods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US8764687May 7, 2008Jul 1, 2014Guided Therapy Systems, LlcMethods and systems for coupling and focusing acoustic energy using a coupler member
US8857438Nov 8, 2011Oct 14, 2014Ulthera, Inc.Devices and methods for acoustic shielding
US8858471Jul 10, 2012Oct 14, 2014Guided Therapy Systems, LlcMethods and systems for ultrasound treatment
US8868958Apr 23, 2012Oct 21, 2014Ardent Sound, IncMethod and system for enhancing computer peripheral safety
US8915853Mar 15, 2013Dec 23, 2014Guided Therapy Systems, LlcMethods for face and neck lifts
US8915854Jan 27, 2014Dec 23, 2014Guided Therapy Systems, LlcMethod for fat and cellulite reduction
US8915870Oct 6, 2009Dec 23, 2014Guided Therapy Systems, LlcMethod and system for treating stretch marks
US8920324Feb 27, 2014Dec 30, 2014Guided Therapy Systems, LlcEnergy based fat reduction
US8932224 *Jul 25, 2013Jan 13, 2015Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US8961511Feb 7, 2007Feb 24, 2015Viveve, Inc.Vaginal remodeling device and methods
US9011336May 7, 2008Apr 21, 2015Guided Therapy Systems, LlcMethod and system for combined energy therapy profile
US9011337Jul 11, 2012Apr 21, 2015Guided Therapy Systems, LlcSystems and methods for monitoring and controlling ultrasound power output and stability
US9039617May 6, 2014May 26, 2015Guided Therapy Systems, LlcMethods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9039619Jan 31, 2014May 26, 2015Guided Therapy Systems, L.L.C.Methods for treating skin laxity
US9095697Aug 13, 2013Aug 4, 2015Guided Therapy Systems, LlcMethods for preheating tissue for cosmetic treatment of the face and body
US9114247Nov 10, 2011Aug 25, 2015Guided Therapy Systems, LlcMethod and system for ultrasound treatment with a multi-directional transducer
US9132031Sep 26, 2006Sep 15, 2015Zeltiq Aesthetics, Inc.Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US9149658Aug 2, 2011Oct 6, 2015Guided Therapy Systems, LlcSystems and methods for ultrasound treatment
US9216276May 7, 2008Dec 22, 2015Guided Therapy Systems, LlcMethods and systems for modulating medicants using acoustic energy
US9220564 *Nov 15, 2005Dec 29, 2015Koninklijke Philips N.V.Electromagnetic radiation delivery apparatus
US9241683Oct 4, 2006Jan 26, 2016Ardent Sound Inc.Ultrasound system and method for imaging and/or measuring displacement of moving tissue and fluid
US9263663Apr 15, 2013Feb 16, 2016Ardent Sound, Inc.Method of making thick film transducer arrays
US9271785Sep 16, 2010Mar 1, 2016Viveve, Inc.Vaginal remodeling device and methods
US9272162Jul 8, 2013Mar 1, 2016Guided Therapy Systems, LlcImaging, therapy, and temperature monitoring ultrasonic method
US9283409Nov 21, 2014Mar 15, 2016Guided Therapy Systems, LlcEnergy based fat reduction
US9283410Nov 21, 2014Mar 15, 2016Guided Therapy Systems, L.L.C.System and method for fat and cellulite reduction
US9314368Jan 25, 2011Apr 19, 2016Zeltiq Aesthetics, Inc.Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associates devices, systems and methods
US9320537Aug 12, 2013Apr 26, 2016Guided Therapy Systems, LlcMethods for noninvasive skin tightening
US9345910Apr 6, 2015May 24, 2016Guided Therapy Systems LlcMethods and systems for generating thermal bubbles for improved ultrasound imaging and therapy
US9351792Jul 19, 2007May 31, 2016The General Hospital CorporationMethod and apparatus for dermatological treatment and fractional skin resurfacing
US9375345Sep 14, 2012Jun 28, 2016Zeltiq Aesthetics, Inc.Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US9408745Sep 14, 2012Aug 9, 2016Zeltiq Aesthetics, Inc.Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US9415235Mar 15, 2013Aug 16, 2016Viveve, Inc.Vaginal remodeling device and method
US9421029Dec 16, 2014Aug 23, 2016Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US9427285Apr 21, 2008Aug 30, 2016Miramar Labs, Inc.Systems and methods for creating an effect using microwave energy to specified tissue
US9427600Apr 21, 2015Aug 30, 2016Guided Therapy Systems, L.L.C.Systems for treating skin laxity
US9427601Nov 26, 2014Aug 30, 2016Guided Therapy Systems, LlcMethods for face and neck lifts
US9440096Nov 26, 2014Sep 13, 2016Guided Therapy Systems, LlcMethod and system for treating stretch marks
US9452302Jul 10, 2012Sep 27, 2016Guided Therapy Systems, LlcSystems and methods for accelerating healing of implanted material and/or native tissue
US9486285Aug 13, 2012Nov 8, 2016Candela CorporationTreatment of skin by spatial modulation of thermal heating
US9504446Jul 11, 2012Nov 29, 2016Guided Therapy Systems, LlcSystems and methods for coupling an ultrasound source to tissue
US9510802Mar 25, 2014Dec 6, 2016Guided Therapy Systems, LlcReflective ultrasound technology for dermatological treatments
US9522290Feb 11, 2016Dec 20, 2016Guided Therapy Systems, LlcSystem and method for fat and cellulite reduction
US9533175Feb 11, 2016Jan 3, 2017Guided Therapy Systems, LlcEnergy based fat reduction
US9545523Mar 14, 2013Jan 17, 2017Zeltiq Aesthetics, Inc.Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
US9566454Apr 23, 2007Feb 14, 2017Guided Therapy Systems, LlcMethod and sysem for non-ablative acne treatment and prevention
US9655770Aug 6, 2013May 23, 2017Zeltiq Aesthetics, Inc.System for treating lipid-rich regions
US9694211Aug 26, 2016Jul 4, 2017Guided Therapy Systems, L.L.C.Systems for treating skin laxity
US9694212Sep 9, 2016Jul 4, 2017Guided Therapy Systems, LlcMethod and system for ultrasound treatment of skin
US9700340Jun 11, 2013Jul 11, 2017Guided Therapy Systems, LlcSystem and method for ultra-high frequency ultrasound treatment
US9707412Dec 9, 2016Jul 18, 2017Guided Therapy Systems, LlcSystem and method for fat and cellulite reduction
US9713731Dec 15, 2016Jul 25, 2017Guided Therapy Systems, LlcEnergy based fat reduction
US9737434May 6, 2013Aug 22, 2017Zeltiq Aestehtics, Inc.Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
US20030216719 *Feb 14, 2003Nov 20, 2003Len DebenedictisMethod and apparatus for treating skin using patterns of optical energy
US20040082940 *Oct 23, 2002Apr 29, 2004Michael BlackDermatological apparatus and method
US20050049582 *Jul 9, 2004Mar 3, 2005Debenedictis Leonard C.Method and apparatus for fractional photo therapy of skin
US20060122584 *Oct 24, 2005Jun 8, 2006Bommannan D BApparatus and method to treat heart disease using lasers to form microchannels
US20060217788 *Dec 22, 2005Sep 28, 2006Herron G SMethod of using laser induced injury to activate topical prodrugs
US20060241573 *Jul 20, 2004Oct 26, 2006Koninklijke Philips Electronics N.V.Electromagnetic radiation delivery apparatus
US20070106349 *Mar 17, 2005May 10, 2007Ziv KarniSystem and method for heating biological tissue via rf energy
US20070198071 *Feb 22, 2006Aug 23, 2007Juniper Medical SystemsCooling device for removing heat from subcutaneous lipid-rich cells
US20070233191 *Feb 7, 2007Oct 4, 2007Parmer Jonathan BVaginal remodeling device and methods
US20070255362 *Apr 27, 2007Nov 1, 2007Juniper Medical, Inc.Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells
US20080009923 *Jun 14, 2007Jan 10, 2008Paithankar Dilip YTreatment of Skin by Spatial Modulation of Thermal Heating
US20080077202 *Nov 9, 2006Mar 27, 2008Juniper Medical, Inc.Tissue Treatment Methods
US20080287839 *May 18, 2007Nov 20, 2008Juniper Medical, Inc.Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US20090149929 *Aug 21, 2008Jun 11, 2009Levinson Mitchell EMonitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090182231 *Jan 8, 2009Jul 16, 2009Guided Therapy Systems, L.L.C.Method and system for treating acne and sebaceous glands
US20090204059 *Apr 20, 2009Aug 13, 2009Mattioli Engineering Ltd.Method and apparatus for skin absorption enhancement and transdermal drug delivery
US20090312693 *Jun 8, 2009Dec 17, 2009Vytronus, Inc.System and method for delivering energy to tissue
US20090326437 *Nov 14, 2007Dec 31, 2009Frank BeerwerthDevice for treating the skin
US20100081971 *Sep 23, 2009Apr 1, 2010Allison John WTreatment planning systems and methods for body contouring applications
US20100152582 *Jun 11, 2009Jun 17, 2010Vytronus, Inc.Handheld system and method for delivering energy to tissue
US20100276609 *Nov 15, 2005Nov 4, 2010Koninklijke Philips Electronics N.V.Electromagnetic radiation delivery apparatus
US20110178584 *Sep 16, 2010Jul 21, 2011Parmer Jonathan BVaginal remodeling device and methods
US20120197120 *Apr 11, 2012Aug 2, 2012Guided Therapy Systems, LlcMethods for treatment of sweat glands
US20120330223 *Sep 4, 2012Dec 27, 2012Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US20130066309 *May 15, 2012Mar 14, 2013Zeltiq Aesthetics, Inc.Tissue treatment methods
US20130310863 *Jul 25, 2013Nov 21, 2013Guided Therapy Systems, LlcEnergy based hyperhidrosis treatment
US20150025420 *Mar 17, 2014Jan 22, 2015Guided Therapy Systems, LlcUltrasound treatment device and methods of use
US20150351838 *Jun 16, 2015Dec 10, 2015Mark E. DeemMethods and apparatus for reducing sweat production
US20160375240 *Jun 26, 2015Dec 29, 2016ActivaDerm, Inc. a Utah CorporationMethod for iontophoretic body fat treatment and related apparatus
USD777338Mar 20, 2014Jan 24, 2017Zeltiq Aesthetics, Inc.Cryotherapy applicator for cooling tissue
CN103930161A *Nov 14, 2012Jul 16, 2014路易斯莫恩Stimulation apparatus
CN104605900A *Nov 4, 2013May 13, 2015上海交通大学医学院附属第九人民医院Skin expander capable of simultaneously providing biological additive effect
EP2285334A1 *Jun 11, 2009Feb 23, 2011Vytronus, Inc.System and method for delivering energy to tissue
EP2285334A4 *Jun 11, 2009Oct 3, 2012Vytronus IncSystem and method for delivering energy to tissue
WO2005009266A1Jul 20, 2004Feb 3, 2005Koninklijke Philips Electronics N.V.Electromagnetic radiation delivery apparatus
WO2005110266A2 *May 10, 2005Nov 24, 2005Koninklijke Philips Electronics N.V.A device for dermatological treatment using light
WO2005110266A3 *May 10, 2005Mar 30, 2006Koninkl Philips Electronics NvA device for dermatological treatment using light
WO2006134426A3 *Nov 15, 2005Apr 19, 2007Rembert FertnerElectromagnetic radiation delivery apparatus
WO2008058716A1 *Nov 14, 2007May 22, 2008Braun GmbhDevice for treating the skin
WO2009152379A1 *Jun 11, 2009Dec 17, 2009Vytronus, Inc.System and method for delivering energy to tissue
WO2015040049A1 *Sep 17, 2014Mar 26, 2015Koninklijke Philips N.V.Treatment device for the skin using radio-frequency electric current
WO2015160076A1 *Jan 27, 2015Oct 22, 2015주식회사 제이에스온High-frequency thermotherapy device
Classifications
U.S. Classification607/99, 607/104
International ClassificationA61N1/30, A61H9/00, A45D44/22, A61B18/12, A61B18/00, A61B18/14, A61B18/20, A61N1/40, A61B19/00, A61N1/28, A61N5/04, A61N5/06
Cooperative ClassificationA61N1/30, A61N5/04, A61B90/02, A61B2018/0066, A61H9/005, A61H9/0071, A61B18/00, A61B18/1206, A61N2005/0645, A61N5/0616, A61B2018/00452, A61B2018/0047, A45D44/22, A61B18/203, A61B18/12, A61B2018/00523, A61N1/403, A61B2018/00488, A61B18/14, A61N1/28
European ClassificationA61B19/24, A61N5/04, A61N1/30, A61B18/12, A45D44/22, A61N1/28, A61B18/14, A61N5/06C2, A61B18/12G, A61N1/40T
Legal Events
DateCodeEventDescription
Feb 17, 1998ASAssignment
Owner name: THERMAGE, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KNOWLTON, EDWARD W.;REEL/FRAME:009014/0720
Effective date: 19971223
May 26, 1999ASAssignment
Owner name: IMPERIAL BANK, CALIFORNIA
Free format text: SECURITY INTEREST;ASSIGNOR:THERMAGE;REEL/FRAME:009987/0187
Effective date: 19981103
Jun 14, 2001ASAssignment
Owner name: IMPERIAL BANK, CALIFORNIA
Free format text: SECURITY INTEREST;ASSIGNOR:THERMAGE;REEL/FRAME:011898/0779
Effective date: 20010515
Dec 9, 2005ASAssignment
Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, CONNECTICUT
Free format text: SECURITY AGREEMENT;ASSIGNOR:THERMAGE, INC.;REEL/FRAME:016871/0391
Effective date: 20050615
Jan 6, 2006FPAYFee payment
Year of fee payment: 4
Mar 9, 2009ASAssignment
Owner name: SOLTA MEDICAL, INC. ( F/K/A/ THERMAGE, INC.), CALI
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION;REEL/FRAME:022354/0737
Effective date: 20090305
Jun 16, 2009ASAssignment
Owner name: SILICON VALLEY BANK, CALIFORNIA
Free format text: SECURITY AGREEMENT;ASSIGNOR:SOLTA MEDICAL, INC.;REEL/FRAME:022824/0837
Effective date: 20090304
Mar 8, 2010REMIMaintenance fee reminder mailed
Jul 30, 2010LAPSLapse for failure to pay maintenance fees
Sep 21, 2010FPExpired due to failure to pay maintenance fee
Effective date: 20100730
Apr 24, 2013ASAssignment
Owner name: SILICON VALLEY BANK, CALIFORNIA
Free format text: SECURITY INTEREST - MEZZANINE LOAN;ASSIGNOR:SOLTA MEDICAL, INC.;REEL/FRAME:030281/0524
Effective date: 20120829
Jan 27, 2014ASAssignment
Owner name: SOLTA MEDICAL, INC., CALIFORNIA
Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:SILICON VALLEY BANK;REEL/FRAME:032126/0475
Effective date: 20140123